Related Experiment Video
Updated: Jan 7, 2026

Generation of Electronic Cigarette Aerosol by a Third-Generation Machine-Vaping Device: Application to Toxicological Studies
Published on: August 25, 2018
Do Young Individuals With Chronic E-Cigarette Exposure Display Cardiopulmonary Abnormalities During Exercise and
Thomas G Williams1, Sophie É Collins2, Andrew R Brotto1
1Division of Pulmonary Medicine, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, AB, Canada; Faculty of Kinesiology, Sport, and Recreation, University of Alberta, Edmonton, AB, Canada.
Background:
The prevalence of e-cigarette use is increasing, and young adults who report e-cigarette use and no history of tobacco smoking report greater respiratory symptoms. Traditional evaluation of resting pulmonary function may fail to detect subclinical abnormalities.
Research Question:
To what extent do otherwise healthy, young adults who report regular e-cigarette use and no tobacco smoking history exhibit altered cardiopulmonary function during exercise and blunted recruitment of pulmonary diffusing capacity for carbon monoxide (Dlco)?
Study Design And Methods:
Twenty participants with chronic e-cigarette exposure (mean age, 23 ± 4 years) with no tobacco smoking history and 20 age-, height-, and sex-matched control participants underwent a pulmonary function test and cardiopulmonary exercise test. Key outcomes included exercise capacity (V˙O2peak), ventilatory efficiency (minute ventilation/CO2 output nadir), exertional dyspnea, and operating lung volumes during exercise. A secondary aim investigated recruitment of resting Dlco and its components, measured as the change from the seated to supine posture. Adjusted linear regression models were used to evaluate the effect of group on key outcome variables at rest and during exercise.
Results:
Both groups presented with normal pulmonary function (all, Pgroup > .05). Individuals who use e-cigarettes exhibited a lower V˙O2peak (Pgroup = .017), elevated minute ventilation/carbon dioxide output nadir (Pgroup = .037), and greater exertional dyspnea (Pgroup < .001, Pgroup∗workload < .001), whereas operating lung volumes did not differ from control participants (all, P > .05). Individuals who use e-cigarettes also displayed a blunted Dlco recruitment to a postural change (Pgroup∗posture = .036). Between-group differences in dyspnea and Dlco recruitment were independent of V˙O2peak.
Interpretation:
In this study, otherwise healthy young adults who report regular e-cigarette use exhibited evidence of abnormal cardiopulmonary responses to exercise and blunted Dlco recruitment. These findings suggest early cardiopulmonary impairment and pulmonary vascular dysfunction in young adults with chronic e-cigarette exposure.
More Related Videos
10:44Comparing the Effects of Electronic Cigarette Vapor and Cigarette Smoke in a Novel In Vivo Exposure System
Published on: May 24, 2017
09:07Author Spotlight: Development and Characterization of an In Vitro Model to Study Chronic Cigarette Smoke Exposure and Its Impact on Airway Epithelial Cells in COPD Research
Published on: July 12, 2024
Related Concept Videos
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-I: Introduction
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: